Esteban Celis

Title: Inventor Esteban Celis: Innovating T Cell Receptors in Augusta, GA

Introduction

Esteban Celis is a notable inventor based in Augusta, Georgia, recognized for his contributions to immunology through innovative patent development. With a focus on human alpha fetoprotein-specific T cell receptors, his work is paving the way for advancements in cancer treatment and therapeutic applications.

Latest Patents

Esteban Celis holds two significant patents pertaining to T cell receptors. His first patent, titled "Human alpha fetoprotein-specific T cell receptors and uses thereof," involves T cell receptors that specifically recognize human alpha fetoprotein (hAFP) and outlines methods for their utilization. The second patent, "Human alpha fetoprotein-specific murine T cell receptors and uses thereof," similarly focuses on murine T cell receptors designed to recognize hAFP, providing detailed methodologies for their application in research and therapy.

Career Highlights

Celiss's professional journey includes notable affiliations with prestigious institutions such as the Augusta University Research Institute, Inc., and the National Institutes of Health (NIH). His expertise in immunology and patient-centered innovations has made him a vital contributor to the scientific community, furthering research initiatives and developing new therapeutic methods.

Collaborations

Throughout his career, Esteban has collaborated with esteemed colleagues, including Yukai He and Wei Zhu. These collaborations have enriched his research endeavors, leading to valuable findings in the realm of T cell receptor development and its medical implications.

Conclusion

In summary, Esteban Celis stands as a prominent figure in the field of immunology through his innovative patents and significant research contributions. His work continues to influence therapeutic strategies, demonstrating the importance of innovation in the medical field and the role of dedicated inventors in advancing human health.